Diagnostic Role of Anti-Mullerian hormone in Polycystic Ovarian Syndrome

Objective: To evaluate if the elevated levels of Anti-Mullerian hormone (AMH) could serve as an indicator polycystic ovarian syndrome (PCOS) in patients presenting with infertility. Method: The present study was conducted at Institute Molecular Biology and Biotechnology, University ofLahore andAustralianConceptInfertilityMedicalCenter(ACIMC),Lahore. It a case control study. Atotal 101 females aged between 20-40 years infertility were included this Among participants, 51 infertile had PCOS 50 non-PCOS subjects. After taking informed consent, medical history anthropometric indices recorded on standardized proforma.Transvaginal ultrasound done to assess morphology. Serum AMH, follicle stimulating (FSH), luteinizing (LH), thyroid (TSH) prolactin measured by commercially available ELISAkits. AMH 10 healthy, fertile having normal menstrual cycle reference values our population. Results: Mean significantly higher (9.9±1.1ng/ml) compared subjects without (1.0± 0.3ng/ml). FSH lower (p value 0.001) but LH: ratio, serum level not different two groups. Conclusion: provides evidence that raised are associated presence therefore can useful marker diagnosis